Formulary Search

Oro-dispersible tablets are more cost effective than oral solution. Reserve oral solution for use in patients where the required dose is not available in an oro-dispersible form.

For use in patients who are unresponsive to lithium.

Initiation and stabilisation by the mental health specialist for at least 1 month before any request for transfer of care to primary care.

Prescribe by BRAND. Lithium carbonate and lithium citrate are not equivalent.

Initiation and stabilisation by the specialist mental health team for at least 1 month before any request to transfer prescribing responsibility to primary care.

SASH- (Tablets non-formulary)

Prescribe by BRAND. Lithium carbonate and lithium citrate are not equivalent.

Initiation and stabilisation by the specialist mental health team for at least 1 month before any request to transfer prescribing responsibility to primary care.

For the prevention of recurrence in bipolar disorder.

Initiation by a Mental Health specialist and stabilisation for a minimum of 1 month before any request to transfer prescribing responsibility.

For the prevention of recurrence in bipolar disorder.

Initiation by a Mental Health specilalist and stabilisation for a minimum of 1 month before any request to transfer prescribing responsibility.

Reserve orodispersible tablets for patients with swallowing difficulties or administration via a PEG tube. 

For bipolar with mania / depression.

Initiation and stabilisation by a Mental Health specialist for a minimum of 1 month before any request for transfer of prescribing responsibility.

For bipolar with mania / depression.

Modified release tablets are reserved for use when immediate release tablets are not suitable.

Modified release quetiapine MAY be continued in Primary Care (after a 3-month period of stabilisation by a Mental Health specialist) where the use of immediate release tablets would risk destabilising the patient.

Off-label use. Licesned product is valproic acid (valproate semisodium).

Initiation and stabilisation by the mental health specialist team for at least 1 month before any request for transfer of prescribing responsbility to primary care.

See separate formulary entry for sodium valproate in people WITH childbearing potential - important pregnancy-prevention requirement.

Initiation and stabilisation by the mental health specialist team for at least 1 month before any request for transfer of prescribing responsbility to primary care.

See separate formulary entry for valproic acid in people WITH childbearing potential - important pregnancy-prevention requirement.

Initiation and stabilisation by the mental health specialist team for at least 1 month before any request for transfer of prescribing responsbility to primary care.

Pregnancy prevention requirement - refer to additional information on the PAD (click on drug name to access)

Principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136